Hormonal Contraceptives Market to Grow with a CAGR of 6.78% through 2030
Increasing
awareness about family planning is expected to drive the Global Hormonal
Contraceptives Market growth in the forecast period, 2026-2030.
According
to TechSci Research report, “Hormonal Contraceptives Market -
Global Industry Size, Share, Trends, Opportunity, and Forecast, 2030F”, The
Global Hormonal Contraceptives Market stood at USD 17.25 billion in 2024 and is
anticipated to grow with a CAGR of 6.78% in the forecast period through 2030.
This can be ascribed to the increasing need for preventing unintended pregnancy
along with family planning among the population across the globe. Additionally,
growing health issues associated with teenage pregnancies, and increasing
awareness about modern contraception methods, especially in the developed
countries in North America and Europe are expected to create lucrative
opportunities for market growth in coming years. Besides, the increasing rising
use of oral pills to prevent unplanned pregnancy and rising research and
development activities to develop novel contraceptive pills are further
expected to support the market growth. Also, growing technological advancement
is a key trend for gaining popularity in the hormonal contraceptive market
during the forecast period.
However,
the easy availability of alternatives of contraceptive methods and health risk
associated with the use of contraceptives slow down the growth of the global
hormonal contraceptives market in the forecast period. Similarly, increasing
side effects of using contraceptive pills may hamper the hormonal contraceptive
market growth during the forecast period. Also, a lack of social acceptance
with a negative impact on using contraceptive in emerging countries can further
restrict the growth of the global hormonal contraceptives market.
Browse
over XX market data Figures spread through XX Pages and an in-depth TOC on "Global Hormonal Contraceptives Market".
The Global Hormonal Contraceptives Market is segmented
into method, hormone, regional distribution, and company.
Based on
Hormone, Progestin-only contraceptives are emerging as the fastest-growing
segment in the hormonal contraceptives market. These products, which include
pills, injectables, implants, and intrauterine devices, rely solely on
synthetic progestin hormones to prevent pregnancy, offering a vital alternative
to combination contraceptives (which include both estrogen and progestin). The
rapid rise in demand is primarily driven by a growing preference for safer
options among women who are either sensitive to estrogen or have medical
contraindications to its use. One major driver for this growth is the expansion
of contraceptive access for breastfeeding women, for whom estrogen-containing
methods are typically contraindicated. The World Health Organization (WHO) and
national health authorities like the U.S. Centers for Disease Control and
Prevention (CDC) recommend progestin-only options as safe and effective during
lactation. This clinical endorsement has expanded the use of such methods in
postpartum family planning programs worldwide.
Based on the Region, The Asia Pacific region is emerging as
the fastest-growing market for hormonal contraceptives, driven by a confluence
of demographic, socio-economic, and policy-driven factors. Countries such as
India, China, Indonesia, the Philippines, and Vietnam are at the forefront of
this regional surge due to rising population awareness, government-supported
family planning programs, and increasing urbanization. Rapid economic
development across the region has also improved access to healthcare services
and expanded the reach of contraceptive products to previously underserved
populations. A key growth driver is the strong governmental commitment to
managing population growth through contraception. For example, India’s Ministry
of Health and Family Welfare operates one of the world’s largest public health
initiatives focused on family planning. According to the National Family Health
Survey (NFHS-5, 2019–2021), the use of modern contraceptive methods in India
has increased to 56.5%, with hormonal options such as pills, injectables, and
implants becoming increasingly popular. Similarly, China’s National Health
Commission has promoted a range of reproductive health services in the
post-one-child-policy era, encouraging the use of safe and effective contraception.
Major
companies operating in the Global Hormonal Contraceptives Market are:
- Abbvie,
Inc.
- Afaxys,
Inc.
- Teva
Pharmaceuticals Industries Ltd.
- Bayer
AG
- Merck
KGaA
- Organon
Group of Companies
- Pfizer
Inc.
- Johnson
& Johnson Services, Inc.
- Lupin
Pharmaceuticals, Inc.
- Pregna
International Ltd.
Download Free Sample Report
Customers
can also request for 10% free customization on this report.
“Increasing focus on family planning, favourable regulations by the government and advancements in hormonal contraception is further expected to increase the demand for hormonal contraceptives, thereby supporting the market growth. Similarly, supportive initiatives by various governments to increase contraceptive products will propel the growth of the market during the forecast period. According to the World Health Organization provided guidelines, for the usage of hormonal contraceptives, such as intrauterine devices, progestogen injectables, and implants, for women at greater risk of HIV. Hormonal contraceptives come in a variety of forms, including pills, patches, injections, vaginal rings, and implants” said Mr. Karan Chechi, Research Director of TechSci
Research, a research based global management consulting firm.
“Hormonal
Contraceptives Market - Global Industry Size, Share, Trends, Opportunity,
and Forecast, Segmented By Method (Pill, Intrauterine Device,
Injectable, Vaginal Ring, Implant, Others), By Hormone (Combination Hormonal
Contraceptives, Progestin Only), By Region and Competition, 2020-2030F”, has evaluated the future
growth potential of global hormonal contraceptives market and provides statistics &
information on market size, structure, and future market growth. The report
intends to provide cutting-edge market intelligence and help decision makers
take sound investment decisions. Besides, the report also identifies and
analyzes the emerging trends along with essential drivers, challenges, and
opportunities in global hormonal contraceptives market.
Contact
TechSci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com